Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.455 AUD | +4.60% | -2.15% | +31.88% |
05:37pm | Capital One Initiates Immutep at Overweight Rating With $10 Price Target | MT |
05-15 | Immutep Says Safety Lead-in Phase of Breast Cancer Study Yields 'Encouraging' Data | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.88% | 345M | |
+33.63% | 50.85B | |
+0.77% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.93% | 26.11B | |
-21.69% | 19.13B | |
+8.94% | 13.05B | |
+27.42% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- IMM Stock
- News Immutep Limited
- Maxim Group Adjusts Price Target on Immutep to $10 From $8, Keeps Buy Rating